Home/Filings/4/0001209191-14-066476
4//SEC Filing

XRS Corp 4

Accession 0001209191-14-066476

CIK 0000854398operating

Filed

Nov 3, 7:00 PM ET

Accepted

Nov 4, 9:45 PM ET

Size

75.6 KB

Accession

0001209191-14-066476

Insider Transaction Report

Form 4
Period: 2014-10-31
Transactions
  • Other

    Series B Preferred Stock

    2014-10-31$5.60/sh2,188,217$12,254,0150 total(indirect: See footnotes)
    Exercise: $2.54Common stock, $0.01 par value (2,188,217 underlying)
  • Other

    Series B Preferred Stock

    2014-10-31$5.60/sh12,136$67,9620 total(indirect: See footnotes)
    Exercise: $2.54Common stock, $0.01 par value (12,136 underlying)
  • Other

    Series B Preferred Stock

    2014-10-31$5.60/sh63,336$354,6820 total(indirect: See footnotes)
    Exercise: $2.54Common stock, $0.01 par value (63,336 underlying)
  • Other

    Series B Preferred Stock

    2014-10-31$5.60/sh166,246$930,9780 total(indirect: See footnotes)
    Exercise: $2.54Common stock, $0.01 par value (166,246 underlying)
  • Other

    Series B Preferred Stock

    2014-10-31$5.60/sh12,719$71,2260 total(indirect: See footnotes)
    Exercise: $2.54Common stock, $0.01 par value (12,719 underlying)
  • Other

    Series C Preferred Stock

    2014-10-31$5.60/sh6,607$36,9990 total(indirect: See footnotes)
    Exercise: $3.94Common stock, $0.01 par value (6,607 underlying)
  • Other

    Series C Preferred Stock

    2014-10-31$5.60/sh86,370$483,6720 total(indirect: See footnotes)
    Exercise: $3.94Common stock, $0.01 par value (86,370 underlying)
  • Other

    Series D Preferred Stock

    2014-10-31$5.60/sh106,621$597,0780 total(indirect: See footnotes)
    Exercise: $3.83Common stock, $0.01 par value (106,621 underlying)
  • Other

    Warrant to purchase common stock, $0.01 par value

    2014-10-31$1.77/sh815.6$1,4440 total(indirect: See footnotes)
    Exercise: $3.83Exp: 2019-08-29Common stock, $0.01 par value (815.6 underlying)
  • Other

    Warrant to purchase common stock, $0.01 par value

    2014-10-31$1.77/sh778.3$1,3780 total(indirect: See footnotes)
    Exercise: $3.83Exp: 2019-08-29Common stock, $0.01 par value (4,062 underlying)
  • Other

    Series C Preferred Stock

    2014-10-31$5.60/sh1,136,849$6,366,3540 total(indirect: See footnotes)
    Exercise: $3.94Common stock, $0.01 par value (1,136,849 underlying)
  • Other

    Series D Preferred Stock

    2014-10-31$5.60/sh1,403,400$7,859,0400 total(indirect: See footnotes)
    Exercise: $3.83Common stock, $0.01 par value (1,403,400 underlying)
  • Other

    Series D Preferred Stock

    2014-10-31$5.60/sh40,620$227,4720 total(indirect: See footnotes)
    Exercise: $3.83Common stock, $0.01 par value (40,620 underlying)
  • Other

    Warrant to purchase common stock, $0.01 par value

    2014-10-31$1.77/sh140,340$248,4020 total(indirect: See footnotes)
    Exercise: $3.83Exp: 2019-08-29Common stock, $0.01 par value (140,340 underlying)
  • Other

    Warrant to purchase common stock, $0.01 par value

    2014-10-31$1.77/sh10,662.1$18,8720 total(indirect: See footnotes)
    Exercise: $3.83Exp: 2019-08-29Common stock, $0.01 par value (20,694 underlying)
  • Other

    Series F Preferred Stock

    2014-10-31$5.60/sh5,277$29,5510 total(indirect: See footnotes)
    Exercise: $2.22Common stock, $0.01 par value (5,277 underlying)
  • Other

    Series F Preferred Stock

    2014-10-31$5.60/sh68,980$386,2880 total(indirect: See footnotes)
    Exercise: $2.22Common stock, $0.01 par value (68,980 underlying)
  • Other

    Warrant to purchase common stock, $0.01 par value

    2014-10-31$3.38/sh272,382$920,6510 total(indirect: See footnotes)
    Exercise: $2.22Exp: 2016-02-12Common stock, $0.01 par value (272,382 underlying)
  • Other

    Warrant to purchase common stock, $0.01 par value

    2014-10-31$3.38/sh1,583$5,3510 total(indirect: See footnotes)
    Exercise: $2.22Exp: 2016-02-12Common stock, $0.01 par value (1,583 underlying)
  • Other

    Warrant to purchase common stock, $0.01 par value

    2014-10-31$3.38/sh1,511$5,1070 total(indirect: See footnotes)
    Exercise: $2.22Exp: 2016-02-12Common stock, $0.01 par value (1,511 underlying)
  • Other

    Warrant to purchase common stock, $0.01 par value

    2014-10-31$3.38/sh7,884$26,6480 total(indirect: See footnotes)
    Exercise: $2.22Exp: 2016-02-12Common stock, $0.01 par value (7,884 underlying)
  • Other

    Warrant to purchase common stock, $0.01 par value

    2014-10-31$3.38/sh20,694$69,9460 total(indirect: See footnotes)
    Exercise: $2.22Exp: 2016-02-12Common stock, $0.01 par value (20,694 underlying)
  • Other

    Series C Preferred Stock

    2014-10-31$5.60/sh6,305$35,3080 total(indirect: See footnotes)
    Exercise: $3.94Common stock, $0.01 par value (6,305 underlying)
  • Other

    Series C Preferred Stock

    2014-10-31$5.60/sh32,905$184,2680 total(indirect: See footnotes)
    Exercise: $3.94Common stock, $0.01 par value (32,905 underlying)
  • Other

    Series D Preferred Stock

    2014-10-31$5.60/sh8,156$45,6740 total(indirect: See footnotes)
    Exercise: $3.83Common stock, $0.01 par value (8,156 underlying)
  • Other

    Series D Preferred Stock

    2014-10-31$5.60/sh7,783$43,5850 total(indirect: See footnotes)
    Exercise: $3.83Common stock, $0.01 par value (7,783 underlying)
  • Other

    Warrant to purchase common stock, $0.01 par value

    2014-10-31$1.77/sh4,062$7,1900 total(indirect: See footnotes)
    Exercise: $3.83Exp: 2019-08-29Common stock, $0.01 par value (10,662.1 underlying)
  • Other

    Series F Preferred Stock

    2014-10-31$5.60/sh907,942$5,084,4750 total(indirect: See footnotes)
    Exercise: $2.22Common stock, $0.01 par value (907,942 underlying)
  • Other

    Series F Preferred Stock

    2014-10-31$5.60/sh5,036$28,2020 total(indirect: See footnotes)
    Exercise: $2.22Common stock, $0.01 par value (5,036 underlying)
  • Other

    Series F Preferred Stock

    2014-10-31$5.60/sh26,279$147,1620 total(indirect: See footnotes)
    Exercise: $2.22Common stock, $0.01 par value (26,279 underlying)
Footnotes (7)
  • [F1]Pursuant to the Merger Agreement, each such share of Preferred Stock was converted into the right to receive an amount in cash, without interest, equal to the product of (x) the number of shares of issuer common stock into which such shares of Preferred Stock would have been converted had the reporting person converted such shares into issuer common stock immediately prior to the closing of the Merger multiplied by (y) the consideration payable to the holders of issuer common stock pursuant to the Merger ($5.60 per share). Each share of Preferred Stock was convertible into one share of common stock of the issuer as of the transaction date.
  • [F2]These securities are owned by Trident Capital Fund-V, L.P.
  • [F3]These securities are owned by Trident Capital Fund-V Affiliates Fund, L.P.
  • [F4]These securities are owned by Trident Capital Fund-V Affiliates Fund (Q), L.P.
  • [F5]These securities are owned by Trident Capital Fund-V Principals Fund, L.P.
  • [F6]These securities are owned by Trident Capital Parallel Fund-V, C.V.
  • [F7]Cancelled in connection with the Merger and converted into the right to receive an amount equal to (i) the total number of shares of issuer common stock subject to such warrant immediately prior to the effective time of the Merger (without regard to vesting) multiplied by (ii) the excess, if any, of (x) the consideration payable to holders of issuer common stock pursuant to the Merger ($5.60 per share) over (y) the exercise price payable per share of issuer common stock under such warrant.

Issuer

XRS Corp

CIK 0000854398

Entity typeoperating
IncorporatedMN

Related Parties

1
  • filerCIK 0000854398

Filing Metadata

Form type
4
Filed
Nov 3, 7:00 PM ET
Accepted
Nov 4, 9:45 PM ET
Size
75.6 KB